[Albendazole in the treatment of strongyloidiasis. Report of 66 cases].
Albendazole, a new broad spectrum anthelmintic, has been tested in 66 adult patients infected by S. stercoralis. 77.2% cure rate was observed following 800 mg once a day for 3 consecutive days, based on repeated fecal examinations using a concentration technic (Junod) and a Baermann test, carried out during 6 to 9 months following treatment. Associated ancylostomiasis caused by N. americanus and trichuriasis were also completely cured (100%). Based on clinical side effects and laboratory investigations, the drug did not produce any significant adverse reactions.